R. Michael Rodgers
Presidente presso Alare Capital Partners LLC
Profilo
R.
Michael Rodgers is currently the Chairman at Alare Capital Partners LLC and a Member at AICPA Foundation, Inc. He has formerly worked as the Chief Financial Officer, Secretary & Treasurer at Ventana Medical Systems, Inc., Principal at ImaRx Therapeutics, Inc., and Chief Operating & Financial Officer at International Genomics Consortium.
He has an undergraduate degree from Menlo College and an MBA from the University of Houston.
Posizioni attive di R. Michael Rodgers
| Società | Posizione | Inizio |
|---|---|---|
Alare Capital Partners LLC
 Alare Capital Partners LLC Investment ManagersFinance Alare Capital Partners LLC provides investment advisory services. The firm provides services to the life sciences, technology, branded consumer and renewable energy sectors. The company was founded in 2005 and is headquartered in Phoenix, AZ. | Presidente | 22/04/2009 |
| AICPA Foundation, Inc. | Corporate Officer/Principal | 23/04/2009 |
Precedenti posizioni note di R. Michael Rodgers
| Società | Posizione | Fine |
|---|---|---|
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Direttore Finanziario/CFO | 24/04/2009 |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Corporate Officer/Principal | - |
| International Genomics Consortium | Direttore Finanziario/CFO | - |
Formazione di R. Michael Rodgers
| Menlo College | Undergraduate Degree |
| University of Houston | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Alare Capital Partners LLC
Alare Capital Partners LLC Investment ManagersFinance Alare Capital Partners LLC provides investment advisory services. The firm provides services to the life sciences, technology, branded consumer and renewable energy sectors. The company was founded in 2005 and is headquartered in Phoenix, AZ. | Finance |
| AICPA Foundation, Inc. | |
| International Genomics Consortium | |
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
- Borsa valori
- Insiders
- R. Michael Rodgers
